TP53 and cancer: Emerging evidence suggests mutated TP53 can equip cancer cells with the ability to cope with challenging conditions during tumorigenesis, including DNA damage, proteotoxic stress, and nutrient fluctuations—conditions that significantly overlap with aneuploidy-induced cellular stresses (124).